Junxian Ou

1.1k total citations · 1 hit paper
19 papers, 563 citations indexed

About

Junxian Ou is a scholar working on Infectious Diseases, Genetics and Molecular Biology. According to data from OpenAlex, Junxian Ou has authored 19 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Junxian Ou's work include Virus-based gene therapy research (12 papers), Viral gastroenteritis research and epidemiology (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Junxian Ou is often cited by papers focused on Virus-based gene therapy research (12 papers), Viral gastroenteritis research and epidemiology (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Junxian Ou collaborates with scholars based in China, United States and Hong Kong. Junxian Ou's co-authors include Qiwei Zhang, Jianguo Wu, Wendong Lan, Xiaowei Wu, James Chodosh, Donald Seto, Shan Zhao, Wei Zhao, Yuqian Yan and Yi Ren and has published in prestigious journals such as Journal of Virology, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Junxian Ou

18 papers receiving 556 citations

Hit Papers

Tracking SARS-CoV-2 Omicron diverse spike gene mutations ... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxian Ou China 12 412 178 132 99 58 19 563
Wendong Lan China 8 338 0.8× 148 0.8× 62 0.5× 57 0.6× 47 0.8× 9 437
Arturo Torres Ortiz United Kingdom 6 488 1.2× 169 0.9× 41 0.3× 72 0.7× 70 1.2× 9 578
Juanita Pang United Kingdom 6 500 1.2× 162 0.9× 38 0.3× 58 0.6× 74 1.3× 10 597
Cornelius Rohde Germany 7 582 1.4× 165 0.9× 37 0.3× 106 1.1× 69 1.2× 13 740
Ikenna G. Madu United States 9 354 0.9× 155 0.9× 48 0.4× 55 0.6× 142 2.4× 10 492
Hannah Limburg Germany 4 570 1.4× 174 1.0× 35 0.3× 119 1.2× 55 0.9× 6 762
Cheila Rocha Germany 13 725 1.8× 221 1.2× 34 0.3× 89 0.9× 77 1.3× 27 943
Jiao Zhao China 7 286 0.7× 105 0.6× 99 0.8× 38 0.4× 11 0.2× 12 511
Robert C. Mettelman United States 11 388 0.9× 147 0.8× 49 0.4× 106 1.1× 93 1.6× 14 640

Countries citing papers authored by Junxian Ou

Since Specialization
Citations

This map shows the geographic impact of Junxian Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxian Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxian Ou more than expected).

Fields of papers citing papers by Junxian Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxian Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxian Ou. The network helps show where Junxian Ou may publish in the future.

Co-authorship network of co-authors of Junxian Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Junxian Ou. A scholar is included among the top collaborators of Junxian Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxian Ou. Junxian Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Yiqiang, Jiangtao Wu, Dingbin Chen, et al.. (2025). High case fatality rate of human adenovirus type 7 infections in children: a meta-analysis and phylogenetic study of HAdV-7 epidemics over the past seven decades. Emerging Microbes & Infections. 14(1). 2582911–2582911.
2.
Xiao, Heng, Miaomiao Shen, Weiwei Ge, et al.. (2025). The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling. PLoS Pathogens. 21(1). e1012886–e1012886. 5 indexed citations
3.
Chen, Dingbin, Yuqian Yan, Ting Mei, et al.. (2024). Construction and validation of a mouse model for studying severe human adenovirus infections. Virologica Sinica. 39(6). 963–973. 1 indexed citations
4.
Bai, Ru, Junxian Ou, Wenya Dong, et al.. (2024). Clinical characteristics and phylogenetic analysis of human enteric adenovirus type 41 (HAdV-F41) from children with gastroenteritis during SARS-CoV-2 pandemic. Infection Genetics and Evolution. 123. 105619–105619. 1 indexed citations
5.
Lan, Wendong, Yiqiang Li, Junxian Ou, et al.. (2023). Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines. Journal of Virology. 97(10). e0101423–e0101423. 5 indexed citations
8.
Ou, Junxian, Wendong Lan, Xiaowei Wu, et al.. (2022). Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events. Signal Transduction and Targeted Therapy. 7(1). 138–138. 137 indexed citations breakdown →
9.
Zhang, Jing, Kui Ma, Xiangyu Wang, et al.. (2021). Desmoglein 2 (DSG2) Is A Receptor of Human Adenovirus Type 55 Causing Adult Severe Community-Acquired Pneumonia. Virologica Sinica. 36(6). 1400–1410. 8 indexed citations
10.
Ou, Junxian, Zhonghua Zhou, Ruixue Dai, et al.. (2021). V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Journal of Virology. 95(16). e0061721–e0061721. 75 indexed citations
11.
Zhao, Shan, Kui Ma, Yuqian Yan, et al.. (2021). Development and Application of a Fast Method to Acquire the Accurate Whole-Genome Sequences of Human Adenoviruses. Frontiers in Microbiology. 12. 661382–661382. 4 indexed citations
13.
Lan, Wendong, Jing Zhang, Shan Zhao, et al.. (2020). COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine. Virologica Sinica. 35(6). 685–698. 24 indexed citations
14.
Yan, Yuqian, Junxian Ou, Shan Zhao, et al.. (2020). Characterization of Influenza A and B Viruses Circulating in Southern China During the 2017–2018 Season. Frontiers in Microbiology. 11. 1079–1079. 15 indexed citations
15.
Zhou, Zhonghua, Ziyi Yang, Junxian Ou, et al.. (2020). Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome. Computational and Structural Biotechnology Journal. 19. 161–167. 32 indexed citations
16.
Zhao, Jing, Shan Zhao, Junxian Ou, et al.. (2020). COVID-19: Coronavirus Vaccine Development Updates. Frontiers in Immunology. 11. 602256–602256. 131 indexed citations
17.
Dehghan, Shoaleh, Siddharth Sridhar, Susanna K. P. Lau, et al.. (2019). A Survey of Recent Adenoviral Respiratory Pathogens in Hong Kong Reveals Emergent and Recombinant Human Adenovirus Type 4 (HAdV-E4) Circulating in Civilian Populations. Viruses. 11(2). 129–129. 34 indexed citations
18.
Pan, Haibin, Yuqian Yan, Jing Zhang, et al.. (2018). Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly. Viruses. 10(10). 568–568. 13 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026